Hospital Admission Risk Program RMH Service
We provide treatment, care and support for people with chronic and complex health issues.
https://www.thermh.org.au/services/community-services/hospital-admission-risk-programThe TRANSCEND study – testing a new medicine for kidney transplant rejection Research study
This study is testing a new medication called felzartamab for people who have received a kidney transplant and developed a type of rejection called late antibody-mediated rejection (AMR).
https://www.thermh.org.au/research/clinical-trials-research-studies/the-transcend-studyThe RMH and WEHI announce new $100m centre for immunology News article
A world-leading immunology research centre that will look at the immune system in greater depth than ever before will be established here in Parkville, thanks to a generous $100m investment from the Snow Medical Research Foundation.
https://www.thermh.org.au/news/the-rmh-and-wehi-announce-new-100m-centre-for-immunologyAt the Royal Melbourne Hospital, we acknowledge that reconciliation is a relationship and an ongoing journey. Our Reconciliation Action Plan demonstrates our commitment to improving our services and the health and wellbeing of First Nations peoples.
https://www.thermh.org.au/about/strategies-plans/reconciliation-action-planResearchers discover genes behind antibiotic resistance in deadly superbug infections News article
Australian researchers have uncovered new genetic insights into Staphylococcus aureus, revealing what makes the bacterium so dangerous when it enters the blood.
https://www.thermh.org.au/news/researchers-discover-genes-behind-antibiotic-resistance-in-deadly-superbug-infectionsAs part of our medical education training, we use an online learning platform called the RMH Learning Hub.
https://www.thermh.org.au/health-professionals/careers/medicine-at-the-rmh/medical-education/elearningEfgartigimod for the treatment of pemphigus vulgaris or pemphigus foliaceous Research study
A clinical trial to assess how safe and effective the study drug. efgartigimod, is in treating participants with pemphigus who are also receiving oral corticosteroids.
https://www.thermh.org.au/research/clinical-trials-research-studies/efgartigimod-for-the-treatment-of-pemphigus-vulgaris-or-pemphigus-foliaceousThe IMAGINATION study Research study
This study is for people with a kidney condition called IgA nephropathy (IgAN), especially those at risk of their condition getting worse.
https://www.thermh.org.au/research/clinical-trials-research-studies/the-imagination-studyThe RMH and WEHI join forces to develop blood test to diagnose dementia News article
The Royal Melbourne Hospital’s (RMH) Associate Professor Cherie Chiang and WEHI's Associate Professor Andrew Webb are developing an early diagnosis test for dementia at the Colonial Foundation Healthy Ageing Centre.
https://www.thermh.org.au/news/the-rmh-and-wehi-join-forces-to-develop-blood-test-to-diagnose-dementiaResidential In Reach RMH Service
Our Residential In Reach (RIR) is an acute referral service that aims to provide clinical assistance and support for residents at residential aged care facilities (RACFs).
https://www.thermh.org.au/services/community-services/rmh-residential-in-reachFamily or friends sometimes take photos or videos of patients during their hospital stay. There are some important factors you need to consider before taking any photos or videos in hospital.
https://www.thermh.org.au/your-care/hospital-care/your-hospital-stay/patient-staff-privacy-photos-videos-recordingsThe RMH Endocrinologist wins 2020 Young Investigator of the Year Award News article
The RMH Endocrinologist Dr Rahul Barmanray has won the 2020 Australasian Diabetes Society President’s Clinical Young Investigator of the Year Award.
https://www.thermh.org.au/news/the-rmh-endocrinologist-wins-2020-young-investigator-of-the-year-awardMobile stroke ambulance trial likely to change international guidelines News article
New data from the International Stroke Conference 2021 confirms that mobile stroke ambulances have an essential role to play in pre-hospital stroke care around the world.
https://www.thermh.org.au/news/mobile-stroke-ambulance-trial-likely-to-change-international-guidelinesDr Kate Martin recognised in 26 January Honours News article
Congratulations to Kate Martin AM who was recognised at the 26 January Honours.
https://www.thermh.org.au/news/dr-kate-martin-recognised-in-26-january-honoursThe Royal Melbourne Hospital (RMH) Clinical School coordinates medical elective requests from Australian and overseas medical students in addition to teaching medical students from the University of Melbourne.
https://www.thermh.org.au/health-professionals/careers/medicine-at-the-rmh/medical-education/medical-elective-programThe Department of Anaesthesia and Pain Management has a proud history of conducting quality research.
https://www.thermh.org.au/services/anaesthesia-pain-management/anaesthesia-researchDiabetes is the name given to a group of different conditions in which there is too much glucose in the blood.
https://www.thermh.org.au/services/diabetes-endocrinology/learn-about/about-diabetes‘Beyond thankful’ for care after contracting COVID-19 News article
There was nothing ordinary about the way Cheryl Poon showed her gratitude for the care she received after being hospitalised at the Royal Melbourne Hospital (RMH) with COVID-19 earlier this year.
https://www.thermh.org.au/news/beyond-thankful-for-care-after-contracting-covid-19Inner Melbourne Community Legal provides free legal advice for patients.
https://www.thermh.org.au/your-care/hospital-care/your-hospital-stay/legal-adviceMirikizumab for moderate to severely active Crohn’s disease Research study
A clinical trial to assess the safety and effectiveness of a new drug, mirikizumab, for moderate to severely active Crohn’s disease.
https://www.thermh.org.au/research/clinical-trials-research-studies/mirikizumab-for-moderate-to-severely-active-crohns-disease